Indiana Code
Chapter 35. Drug Utilization Review
12-15-35-30. Local Practices; Monitoring

Sec. 30. The criteria and standards developed under section 28(a)(3) of this chapter for appropriate prescribing that are implemented must reflect the local practices of physicians to monitor the following:
(1) Therapeutic appropriateness.
(2) Overutilization or underutilization.
(3) Therapeutic duplication.
(4) Drug-disease contraindications.
(5) Drug-drug interactions.
(6) Incorrect drug dosage or duration of drug treatment.
(7) Clinical abuse and misuse.
As added by P.L.75-1992, SEC.19. Amended by P.L.3-2008, SEC.95.

Structure Indiana Code

Indiana Code

Title 12. Human Services

Article 15. Medicaid

Chapter 35. Drug Utilization Review

12-15-35-1. "Appropriate and Medically Necessary" Defined

12-15-35-2. "Board" Defined

12-15-35-3. "Compendia" Defined

12-15-35-4. "Counseling" Defined

12-15-35-4.5. "Covered Outpatient Drug" Defined

12-15-35-5. "Criteria" Defined

12-15-35-6. "Drug-Disease Contraindication" Defined

12-15-35-7. "Drug-Drug Interaction" Defined

12-15-35-8. "Drug Utilization Review" or "Dur" Defined

12-15-35-9. "Intervention" Defined

12-15-35-10. "Overutilization or Underutilization" Defined

12-15-35-11. "Pharmacist" Defined

12-15-35-12. "Physician" Defined

12-15-35-13. "Prospective Dur" Defined

12-15-35-14. "Retrospective Dur" Defined

12-15-35-15. "Standards" Defined

12-15-35-16. "Surs" Defined

12-15-35-17. "Therapeutic Appropriateness" Defined

12-15-35-17.5. "Therapeutic Classification" or "Therapeutic Category" Defined

12-15-35-18. "Therapeutic Duplication" Defined

12-15-35-18.5. Application of Chapter

12-15-35-18.7. Formulary Requirements

12-15-35-19. Drug Utilization Review Board; Establishment

12-15-35-20. Membership of Board

12-15-35-20.1. Conflicts of Interest

12-15-35-20.5. Therapeutics Committee Established; Members; Limitations; Terms; Votes; Meetings

12-15-35-21. Board; Appointment; Term

12-15-35-22. Qualifications of Board Members

12-15-35-23. Physician Appointments; Geographic Balance

12-15-35-24. Reappointment of Members

12-15-35-25. Chairman; Compensation; Expenses

12-15-35-26. Additional Staff

12-15-35-27. Retrospective and Prospective Dur Program Responsibility

12-15-35-28. Duties of the Board; Preferred Drug List; Report

12-15-35-28.5. Therapeutics Committee Duties

12-15-35-28.7. Submitting Initial Preferred Drug List; Limitations on Restrictions; Advance Notice to Providers; Implementation; Prior Authorization Limitation; Rules

12-15-35-29. Quorum; Majority Vote on Dur Criteria and Standards for Prescribing

12-15-35-30. Local Practices; Monitoring

12-15-35-31. Intervention; Approval; Requisites

12-15-35-32. Repealed

12-15-35-32.1. Annual Report Contents

12-15-35-33. Repealed

12-15-35-34. Confidential Identifying Information; Release of Cumulative Nonidentifying Information

12-15-35-35. Prior Approval Program for Outpatient Drugs; Standards

12-15-35-36. Advisory Committees

12-15-35-37. Medicaid State Plan; Inclusion of Retrospective and Prospective Dur Program

12-15-35-38. Dur Program Guidelines and Procedures

12-15-35-39. Retrospective Dur Requisites

12-15-35-40. Prospective Dur Requisites

12-15-35-41. Board Activities Under Ic 34-30-15

12-15-35-42. Meetings

12-15-35-43. Confidentiality; Pharmacist Data and Information

12-15-35-43.5. Prohibiting the Release of Proprietary or Confidential Information Obtained Under Certain Circumstances

12-15-35-44. Confidentiality; Violations; Penalty

12-15-35-45. Outpatient Drug Formulary; Requirements

12-15-35-46. Review of Proposed Formulary

12-15-35-47. Review of Changes to Formulary

12-15-35-48. Board Review of Managed Care Organization Prescription Drug Program

12-15-35-49. Information Provided by Office

12-15-35-50. Maximum Allowable Cost Schedule for Drugs; Pharmacy Participation in Medicaid Program

12-15-35-51. Advisory Committee; Duties; Report